Development of a Molecular Diagnostic Tool for Endometrial Cancer.

Inclusion Criteria: * Post-menopausal women (≥1 year without menstruation) with AUB who present with: 1. Endometrium \> 3mm by transvaginal ultrasound, OR 2. Endometrium ≤ 3mm who meet at least one of the following criteria: i. Persistent symptoms (more than one episode of metrorrhagia) ii. Heterogenous endometrium on transvaginal ultrasonography iii. Risk factors (BMI ≥ 30, use of tamoxifen, hormone replacement therapy (HRT), Lynch syndrome, BRCA mutation. * Obtaining written informed consent Exclusion Criteria: * Women with an active pelvic infection. * Women who have had viral infections with evidence of active and latent disease such as Hepatitis B, Hepatitis C, and HIV infection. Patients who have had Hepatitis C in the past but who have been successfully treated and in whom viral replication has not been observed in the last year will be included.